Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms

Leukemia, Published online: 19 December 2023; doi:10.1038/s41375-023-02110-9Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms

Source: Leukemia - December 19, 2023 Category: Hematology Authors: Tracy Murphy Jacqueline M. Mason Brian Leber Mark R. Bray Steven M. Chan Vikas Gupta Dina Khalaf Dawn Maze Caroline J. McNamara Aaron D. Schimmer Andre C. Schuh Hassan Sibai Michael Trus Debbie Valiquette Kylie Martin Linh Nguyen Xuan Li Tak W. Mak Mark D Source Type: research